Monte Rosa Therapeutics, Inc. (GLUE) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -481.59%.
- 2026-03-31: Pre-Tax Margin -1055.84%.
- 2025-12-31: Pre-Tax Margin -1656.81%.
- 2025-09-30: Pre-Tax Margin -236.98%.
Complete source-backed pre-tax margin history.
- Available history
- 2024-03-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -481.59% |
| 2026-03-31 | -1055.84% |
| 2025-12-31 | -1656.81% |
| 2025-09-30 | -236.98% |
| 2025-06-30 | -47.84% |
| 2025-03-31 | 56.17% |
| 2024-12-31 | 25.72% |
| 2024-09-30 | -258.12% |
| 2024-06-30 | -640.21% |
| 2024-03-31 | -2996.71% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -32.12% |
| 2024-12-31 | -92.74% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |